National Quality Measures Clearinghouse | Measures by Topic: Breast Neoplasms

National Quality Measures Clearinghouse | Measures by Topic: Breast Neoplasms

Measures by Topic

Disease/Condition > Diseases (1465) > Neoplasms (166) > Neoplasms by Site (100) >

Breast Neoplasms (15)

1-15 of 15
1.   Preventive services: percentage of adult enrolled members ages 19 years and older who are up-to-date for all appropriate preventive services. 2011 Oct. NQMC:006906 HealthPartners - Managed Care Organization. View all measures by the developer(s) Compare Selected
2.   Breast cancer screening: percentage of women 40 to 69 years of age who had a mammogram to screen for breast cancer. 2011 Jul. NQMC:007069 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
3.   Radiation oncology: percentage of patients who had radiotherapy for breast conservation (pT1-3, any nodal staging, M0), during the 6 month time period, who had complete follow-up. 2011 Jan. [NQMC Update Pending] NQMC:006819 Australian Council on Healthcare Standards - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
4.   Breast cancer screening: percent of women age 50 to 69 who are screened for breast cancer. 2010 Oct. NQMC:006028 Veterans Health Administration - Federal Government Agency [U.S.]. View all measures by the developer(s) Compare Selected
5.   Oncology: percentage of patients, regardless of age, with a diagnosis of breast, colon, or rectal cancer who are receiving intravenous chemotherapy for whom the planned chemotherapy regimen (which includes, at a minimum: drug[s] prescribed, dose, and duration) is documented prior to the initiation of the new treatment regimen. 2010 Sep. NQMC:003764 American Society for Therapeutic Radiology and Oncology - Medical Specialty Society; American Society of Clinical Oncology - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
6.   Oncology: percentage of patients, regardless of age, with a diagnosis of breast, colon, or rectal cancer who are seen in the ambulatory setting who have a baseline AJCC cancer stage or documentation that the cancer is metastatic in the medical record at least once during the 12 month reporting period. 2010 Sep. NQMC:003761 American Society for Therapeutic Radiology and Oncology - Medical Specialty Society; American Society of Clinical Oncology - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
7.   Pathology: percentage of breast cancer resection pathology reports that include the pT category (primary tumor), the pN category (regional lymph nodes) and the histologic grade. 2010 Sep. NQMC:003482 College of American Pathologists - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
8.   Radiology: percentage of final reports for screening mammograms that are classified "probably benign." 2010 Sep. NQMC:004954 American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
9.   Radiology: percentage of patients aged 40 years and older undergoing a screening mammogram whose information is entered into a reminder system with a target due date for the next mammogram. 2010 Sep. NQMC:004957 American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
10.   Radiology: percentage of patients undergoing diagnostic mammograms that are classified as "suspicious" or "highly suggestive of malignancy" with documentation of direct communication of findings from the diagnostic mammogram to the patient within 5 business days of exam interpretation. 2010 Sep. NQMC:004956 American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
11.   Radiology: percentage of patients undergoing diagnostic mammograms that are classified as "suspicious" or "highly suggestive of malignancy" with documentation of direct communication of findings from the diagnostic mammogram to the practice that manages the patient's on-going care within 3 business days of exam interpretation. 2010 Sep. NQMC:004955 American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
12.   Radiology: percentage of patients undergoing screening mammograms whose assessment category (e.g., Mammography Quality Standards Act [MQSA], Breast Imaging Reporting and Data System [BI-RADS®], or FDA approved equivalent categories) is entered into an internal database that will, at a minimum, allow analysis of abnormal interpretation (recall) rate. 2010 Sep. NQMC:004953 American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
13.   Osteoporosis: percentage of patients aged 18 years and older with one of the following conditions or therapies: receiving oral glucocorticosteroid therapy for greater than 3 months OR hypogonadism OR fracture history OR transplant history OR obesity surgery OR malabsorption disease OR receiving aromatase therapy for breast cancer who had a central dual-energy X-ray absorptiometry (DXA) ordered or performed or pharmacologic therapy prescribed within 12 months. 2009 Nov. NQMC:002957 American Academy of Family Physicians - Medical Specialty Society; American Academy of Orthopaedic Surgeons - Medical Specialty Society; American Association of Clinical Endocrinologists - Medical Specialty Society; American College of Rheumatology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration; The Endocrine Society - Disease Specific Society. View all measures by the developer(s) Compare Selected
14.   Breast cancer: percentage of patients for whom radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer. 2007 Apr. NQMC:002688 American Society of Clinical Oncology/National Comprehensive Cancer Network. View all measures by the developer(s) Compare Selected
15.   Breast cancer: percentage of patients for whom tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year (365 days) of diagnosis for women with AJCC T1c or stage II or III hormone receptor positive breast cancer. 2007 Apr. NQMC:002687 American Society of Clinical Oncology/National Comprehensive Cancer Network. View all measures by the developer(s) Compare Selected
1-15 of 15